1. Home
  2. ATNM vs CCG Comparison

ATNM vs CCG Comparison

Compare ATNM & CCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$0.80

Market Cap

31.7M

Sector

Health Care

ML Signal

HOLD

Logo Cheche Group Inc.

CCG

Cheche Group Inc.

HOLD

Current Price

$14.20

Market Cap

30.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATNM
CCG
Founded
2000
2014
Country
United States
China
Employees
N/A
469
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.7M
30.8M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ATNM
CCG
Price
$0.80
$14.20
Analyst Decision
Strong Buy
Buy
Analyst Count
2
1
Target Price
$4.50
$350.00
AVG Volume (30 Days)
94.4K
43.0K
Earning Date
05-06-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
14.17
N/A
EPS
N/A
N/A
Revenue
$90,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$567.38
P/E Ratio
N/A
N/A
Revenue Growth
11.11
N/A
52 Week Low
$0.74
$0.34
52 Week High
$1.81
$16.83

Technical Indicators

Market Signals
Indicator
ATNM
CCG
Relative Strength Index (RSI) 33.55 68.98
Support Level N/A $0.67
Resistance Level $1.38 $16.83
Average True Range (ATR) 0.04 1.97
MACD -0.00 0.13
Stochastic Oscillator 28.05 46.76

Price Performance

Historical Comparison
ATNM
CCG

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

About CCG Cheche Group Inc.

Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services, and other services in China. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.

Share on Social Networks: